57 results
Page 2 of 3
DEFC14C
ewlulde2
2 Jun 22
Information statement in contested solicitation
4:24pm
PRER14C
qrmutf
31 May 22
Preliminary revised information
5:09pm
CORRESP
etikb
31 May 22
Correspondence with SEC
12:00am
PREC14C
2rmzkgjk7kq16yu83
19 May 22
Preliminary information statement in contested solicitation
5:05pm
10-K/A
c9kfqda2jq8n64l3v
29 Apr 22
Annual report (amended)
4:43pm
DEFC14A
zsy7peske2uk5
29 Apr 22
Proxy in contested solicitation
4:02pm
PRRN14A
77oq8wm0
27 Apr 22
Revised preliminary proxy statement filed by non-management
1:13pm
PREC14A
2kkturhndtd4ufl
26 Apr 22
Preliminary proxy with contested solicitation
8:48am
PRRN14A
myss39n
25 Apr 22
Revised preliminary proxy statement filed by non-management
5:23pm
PREC14A
7ikq1 goau6b88
11 Apr 22
Preliminary proxy with contested solicitation
6:44am
10-K
lxokqlcsv
31 Mar 22
Annual report
8:18am
10-K
EX-4.2
glzx whqnmvhw
31 Mar 22
Annual report
8:18am
8-K
EX-99.1
58uj5zk4i ykpa515
30 Mar 22
Results of Operations and Financial Condition
7:40am
8-K
EX-99.1
1zz 9fhisjdjkugn9
29 Sep 21
Adagio Therapeutics Announces New Data Highlighting the Potential of ADG20 for Treatment and Prevention of COVID-19
4:41pm
10-Q
vlw30n sk16
20 Sep 21
Quarterly report
4:17pm
8-K
EX-3.2
ff8pcqtgelqpc7tjcgv7
10 Aug 21
Amendments to Articles of Incorporation or Bylaws
5:26pm
8-K
EX-3.1
up1kug28856z1mp4oey
10 Aug 21
Amendments to Articles of Incorporation or Bylaws
5:26pm
424B4
nmsox dq0icvp
6 Aug 21
Prospectus supplement with pricing info
4:54pm